Quantification of Poly(I:C)-Mediated Protection against Genital Herpes Simplex Virus Type 2 Infection

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Virology

• Publication date

  2006-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01099-06PMID 17005677PMCID PMC1617314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defining the Antigen-Specific T-Cell Response to Vaccination and Poly(I:C)/TLR3 Signaling: Evidence of Enhanced Primary and Memory CD8 T-Cell Responses and Antitumor Immunity

  2005cited by this paper
• Herpes Simplex Virus and Toll-Like Receptors

  2005cited by this paper
• Innate control of adaptive immunity via remodeling of lymph node feed arteriole.

  2005cited by this paper
• HSV-2 transmission.

  2004cited by this paper
• Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics.

  2004cited by this paper
• Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.

  2004influential reference
• Viral Activation of Macrophages through TLR-Dependent and -Independent Pathways1

  2004cited by this paper
• Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments.

  2004cited by this paper
• Mouse Model of Cervicovaginal Toxicity and Inflammation for Preclinical Evaluation of Topical Vaginal Microbicides

  2004cited by this paper
• TLR9 signals after translocating from the ER to CpG DNA in the lysosome

  2004influential reference
• The potential epidemiological impact of a genital herpes vaccine for women

  2004cited by this paper
• Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.

  2004cited by this paper
• Toxicity and Response Evaluation of the Interferon Inducer Poly ICLC Administered at Low Dose in Advanced Renal Carcinoma and Relapsed or Refractory Lymphoma: A Report of Two Clinical Trials of the Eastern Cooperative Oncology Group

  2004cited by this paper
• Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

  2004cited by this paper
• Innate Immunity to Herpes Simplex Virus Type 2

  2003influential reference
• Toll-like Receptor Signaling*

  2003cited by this paper
• A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

  2003cited by this paper
• Recognition of pathogen-associated molecular patterns by TLR family.

  2003cited by this paper
• Immunostimulatory CpG treatment for genital HSV-2 infections.

  2003cited by this paper
• A Protective Role of Locally Administered Immunostimulatory CpG Oligodeoxynucleotide in a Mouse Model of Genital Herpes Infection

  2003influential reference
• A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways.

  2002cited by this paper
• Viruses and interferon: a fight for supremacy

  2002cited by this paper
• Entry of Inflammatory Cells Into the Mouse Vagina Following Application of Candidate Microbicides: Comparison of Detergent-Based and Sulfated Polymer–Based Agents

  2002cited by this paper
• Induction of the IFN-gamma gene and protein is linked to the establishment of cell polarity in a porcine epithelial cell line.

  2002cited by this paper
• Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994.

  2002cited by this paper
• Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection

  2002influential reference
• The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells.

  2002cited by this paper
• Induction of the IFN-γ gene and protein is linked to the establishment of cell polarity in a porcine epithelial cell line

  2002cited by this paper
• Toll-like receptors: critical proteins linking innate and acquired immunity

  2001cited by this paper
• Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

  2001cited by this paper
• Comparison of Microbicides for Efficacy in Protecting Mice Against Vaginal Challenge With Herpes Simplex Virus Type 2, Cytotoxicity, Antibacterial Properties, and Sperm Immobilization

  2001cited by this paper
• Toll-like receptors in the induction of the innate immune response

  2000cited by this paper
• DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo

  2000cited by this paper
• New developments in the epidemiology, natural history and management of genital herpes.

  1999cited by this paper
• In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model

  1999cited by this paper
• Imiquimod 5% cream (Aldara).

  1998cited by this paper
• T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.

  1998cited by this paper
• Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts

  1998cited by this paper
• Therapeutic blockade of sexually transmitted pathogens.

  1997cited by this paper
• Female-controlled methods to prevent sexual transmission of HIV.

  1996cited by this paper
• Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:PolyC12U in the treatment of HIV infection

  1996cited by this paper
• Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes.

  1995cited by this paper
• Biological response modifier-mediated resistance to herpesvirus infections requires induction of α/β interferon

  1993cited by this paper
• Biological response modifier-mediated resistance to herpesvirus infections requires induction of alpha/beta interferon.

  1993cited by this paper
• The interferons. Mechanisms of action and clinical applications.

  1991cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper

• CARD14/CARMA2sh and TANK differentially regulate poly(I:C)–induced inflammatory reaction in keratinocytes

  2020cites this paper
• Cultivated Human Vaginal Microbiome Communities Impact Zika and Herpes Simplex Virus Replication in ex vivo Vaginal Mucosal Cultures

  2019cites this paper
• The Murine Intravaginal HSV-2 Challenge Model for Investigation of DNA Vaccines.

  2019cites this paper
• IL-36γ Is a Key Regulator of Neutrophil Infiltration in the Vaginal Microenvironment and Limits Neuroinvasion in Genital HSV-2 Infection

  2019influential citation
• In Ovo Administration of Innate Immune Stimulants and Protection from Early Chick Mortalities due to Yolk Sac Infection

  2018cites this paper
• IL‐36&ggr; induces a transient HSV‐2 resistant environment that protects against genital disease and pathogenesis

  2018cites this paper
• Toll-like receptor 3 pathway restricts Marek’s disease virus infection

  2017cites this paper
• A minimal RNA ligand for potent RIG-I activation in living mice

  2017cites this paper
• Long-lasting antiviral innate immune priming in the Lophotrochozoan Pacific oyster, Crassostrea gigas

  2017cites this paper
• IL-36γ Augments Host Defense and Immune Responses in Human Female Reproductive Tract Epithelial Cells

  2016cites this paper
• Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication

  2016cites this paper
• Chlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model

  2016cites this paper
• Cellular Immune Status and Inflammatory Markers in Herpes Simplex Virus Type-2 Sero-positive Pregnant Women

  2016cites this paper
• Animal models of immunity to female genital tract infections and vaccine development

  2015cites this paper
• Induction of interferon- l contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells

  2015cites this paper
• Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.

  2015cites this paper
• TLR9 and RIG-I Signaling in Human Endocervical Epithelial Cells Modulates Inflammatory Responses of Macrophages and Dendritic Cells In Vitro

  2014cites this paper
• Herpes simplex virus 2-induced activation in vaginal cells involves Toll-like receptors 2 and 9 and DNA sensors DAI and IFI16.

  2014cites this paper
• The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.

  2014cites this paper
• TLR3 activation efficiency by high or low molecular mass poly I:C

  2013cites this paper
• Le virus herpès simplex de type 1 et la réponse immunitaire cérébrale innée

  2013cites this paper
• An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2.

  2013cites this paper
• Learning from the Messengers: Innate Sensing of Viruses and Cytokine Regulation of Immunity—Clues for Treatments and Vaccines

  2013cites this paper
• Type I interferons in regulation of mucosal immunity

  2012cites this paper
• Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection.

  2012cites this paper
• Commensal Bacteria Modulate Innate Immune Responses of Vaginal Epithelial Cell Multilayer Cultures

  2012cites this paper
• Intravaginal TLR agonists increase local vaccine-specific CD8 T-cells and human papillomavirus-associated genital-tumor regression in mice

  2012cites this paper
• Sensing herpes: more than toll

  2012cites this paper
• Prophylactic and therapeutic implications of toll‐like receptor ligands

  2012cites this paper
• Polyinosinic-polycytidylic acid attenuates hepatic fibrosis in C57BL/6 mice with Schistosoma japonicum infection.

  2012cites this paper
• Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis.

  2012cites this paper
• Contents lists available at SciVerse ScienceDirect

  2012cites this paper
• TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection

  2011cites this paper
• Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.

  2011cites this paper
• Induction of Innate Immune Responses in the Female Genital Tract: Friend or Foe of HIV‐1 Infection?

  2011cites this paper
• Antitumor Activity from the Combined Application of Poly(I:C) and Chemotherapeutics in Human Metastatic Pharyngeal Cell Lines

  2011cites this paper
• HSV-2: in pursuit of a vaccine.

  2011cites this paper
• Toll-like receptor-mediated recognition of herpes simplex virus.

  2010cites this paper
• Interferon-α vermittelte Immuntherapie in der Friend Retrovirus Infektion

  2010cites this paper
• Development and Characterization of a Three-Dimensional Organotypic Human Vaginal Epithelial Cell Model1

  2010cites this paper
• Anti-virus activity induced by polyinosinic:polycytidylic acid copolymer in in vitro chick embryo fibroblast cells.

  2010cites this paper
• Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy.

  2010cites this paper
• Toll-Like Receptor 3 Agonist Protection against Experimental Francisella tularensis Respiratory Tract Infection

  2010cites this paper
• Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn.

  2010cites this paper
• Toll-Like Receptor 3 Agonist Protection against Experimental Francisella tularensis Respiratory Tract Infection (cid:1)

  2010cites this paper
• This information is current as Cells and Prevents Virus-Induced Disease Functional Properties of Virus-Specific T Friend Retrovirus-Infected Mice Improves Polyinosinic-Polycytidylic Acid Treatment of Ulf Dittmer

  2010cites this paper
• Toll-like receptors and genital tract infection

  2010cites this paper
• Polyinosinic-Polycytidylic Acid Treatment of Friend Retrovirus-Infected Mice Improves Functional Properties of Virus-Specific T Cells and Prevents Virus-Induced Disease

  2010cites this paper
• Salmonella enterica Serovar Typhimurium Exploits Toll-Like Receptor Signaling during the Host-Pathogen Interaction

  2009cites this paper
• Apoptosis induced in chicken embryo fibroblasts in vitro by a polyinosinic:polycytidylic acid copolymer.

  2009cites this paper
• Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women.

  2009cites this paper
• Salmonella exploits Toll-like receptor signaling during the host-pathogen interaction

  2009cites this paper
• FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection

  2009cites this paper
• Innate and Adaptive Immune Responses to Herpes Simplex Virus

  2009cites this paper
• Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection

  2009cites this paper
• The role of the local microenvironment in regulating susceptibility and immune responses to sexually transmitted viruses in the female genital tract.

  2009cites this paper
• Biodegradable polymeric delivery systems for protein subunit vaccines

  2008cites this paper
• Reversible Blockade of Thymic Output: An Inherent Part of TLR Ligand-Mediated Immune Response1

  2008cites this paper
• Double-Stranded RNA Analog Poly(I:C) Inhibits Human Immunodeficiency Virus Amplification in Dendritic Cells via Type I Interferon-Mediated Activation of APOBEC3G

  2008cites this paper
• ORIGINAL ARTICLE: Quantification and Comparison of Toll‐Like Receptor Expression and Responsiveness in Primary and Immortalized Human Female Lower Genital Tract Epithelia

  2008cites this paper
• Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis.

  2008cites this paper
• Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3

  2008cites this paper
• Toll-Like Receptors and Viruses: Induction of Innate Antiviral Immune Responses

  2008cites this paper
• Toll-like receptor signaling in HIV-1 infection: a potential target for therapy?

  2007cites this paper
• Toll‐like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology

  2007cites this paper
• REVIEW ARTICLE: The Role of Toll‐Like Receptor Ligands/Agonists in Protection Against Genital HSV‐2 Infection

  2007cites this paper
• Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management

  2007cites this paper
• Toll-like receptor signaling in HIV-1 infection: a potential target for therapy? 'A widely accepted model of HIV-1 immunopathogenesis postulates that the accelerated immune activation results in proliferation, functional impairment and eventual exhaustion of the immune system.'

  2007cites this paper